| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Victor F Ganzi is Director at ELTX and has filed Form 4s across 3 companies. Victor F Ganzi's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $14.6M at current prices.
Historically, Victor F Ganzi's trades have earned a strong insider score of 84/100 across 4 rated trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +97.4%.
The biggest single holding is WTW (~$7.0M) as Director.
Victor F Ganzi has 18 Form 4 filings on record from February 2021 to February 2026, across 3 companies: Director at Aveanna Healthcare (AVAH), 2021–2026; Director at Elicio Therapeutics (ELTX), 2021–2022; Director at Willis Towers Watson (WTW), 2021–2022.
The 24 reported transactions were 5 stock awards, 5 option or other derivative awards, 4 open-market purchases and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $20K and 1 sale worth about $3.9M.
The largest open-market purchase was 16,808 shares of AVAH at an average $1.15 on June 1, 2023, about $19K. Twelve months later AVAH was up 110%.
The only open-market sale was 246,720 shares of ELTX at an average $16.00 on February 9, 2021, about $3.9M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | AVAH Aveanna Healthcare Holdings, Inc. | Director | Buy | 200 | $1.23 | $246.00 | - | +4.4% | +89.8% | |
| Jun 1, 2023 | AVAH Aveanna Healthcare Holdings, Inc. | Director | Buy | 16,808 | $1.15 | $19,399.29 | +7.7% | +24.2% | +110.5% | |
| Feb 9, 2021 | ELTX Elicio Therapeutics, Inc. | Director | Sell | 246,720 | $16.00 | $3,947,520.00 | -30.0% | - | - |